Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-06-05
2009-02-17
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S311000, C514S314000
Reexamination Certificate
active
07491825
ABSTRACT:
Non-peptide compounds of formula (I) having activity as specific antagonists of bradykinin (BK) B2 receptor. The compounds are chemically characterized by the presence of an alpha, alpha-disubstituted amino acid at least one amino group, free or salified, or the corresponding ammonium quaternary salt. These BK receptor antagonists are a novel class of medicaments which can be used in all the disorders in which the receptors are involved.
REFERENCES:
patent: 5859025 (1999-01-01), Wagner et al.
patent: 5968951 (1999-10-01), Dodey et al.
patent: 6063791 (2000-05-01), Barth et al.
patent: 6140341 (2000-10-01), Heitsch et al.
patent: 6211196 (2001-04-01), Heitsch et al.
Akbary, A.M., Immunopharmacology, vol. 33, pp. 238-242, 1996.
Osteoarthr. Cartil. vol. 12, S137, p. 332, 2004.
Turner, J Allergy Clin Immunol, pp. 105-113, vol. 107 (1), 2001.
Calvani Federico
Catrambone Fernando
Felicetti Patrizia
Fincham Christopher Ingo
Giolitti Alessandro
Menarini Ricerche S.p.A.
Seaman D. Margaret
Young & Thompson
LandOfFree
Basic non-peptide bradykinin antagonists and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Basic non-peptide bradykinin antagonists and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Basic non-peptide bradykinin antagonists and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4062908